These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1626)

  • 1. [The effect of pentoxifyllin on the cyclic AMP-system in thrombocytes].
    Stefanovich V; Jarvis P; Grigoleit HG
    Med Welt; 1975 Dec; 26(49):2230-3. PubMed ID: 1626
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of pentoxifyllin on the characteristic phenomenons of thrombocyte aggregation and fragmentation].
    Wenzel E; Rietkötter U; Otte B; Holzhüter H; Bahre G; Volkmer I; Kaminsky R
    Med Welt; 1975 Nov; 26(46):2100-2. PubMed ID: 1196103
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of syntophyllin and caffeine on the level and uptake of serotonin by thrombocytes and their effect on the inhibition of thrombocyte aggregation.
    Rysánek K; König J; Růzicková S; Spánková H
    Act Nerv Super (Praha); 1972; 14(2):135-6. PubMed ID: 4339151
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F; Vulliemoz Y; Verosky Y; Triner L
    Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of aggregation inducers and inhibitors on the pentosephosphate pathway enzymes of glucose conversion in the thrombocytes].
    Nikulin AA; Aksenova VM; Petrovich IuA
    Farmakol Toksikol; 1979; 42(3):254-7. PubMed ID: 221244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets].
    Nikulin AA
    Farmakol Toksikol; 1978; 41(2):177-82. PubMed ID: 207563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drugs on the activity of thrombocytes 3,5-cyclic AMP phosphodiesterase.
    Rysánek K; Spánkova H; Mlejnkova M; Synek P
    Int J Clin Pharmacol; 1974 Jul; 10(1):30-2. PubMed ID: 4368616
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition and reversal of platelet aggregation by methyl xanthines.
    Ardlie NG; Glew G; Schultz BG; Schwartz CJ
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):670-3. PubMed ID: 4968854
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191).
    Gastpar H
    Thromb Res; 1974 Sep; 5(3):277-89. PubMed ID: 4373868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.